相关实验视频

Updated: May 16, 2025

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

拜卡莱因与阿佐尔结合,用于抗菌类in vitro

Mengmin Liang¹, Qingwen Hu², Junhao Yu²

¹School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, China.

Frontiers in microbiology

|April 4, 2025

概括

拜卡莱因 (BE) 与波萨可纳 (POS) 结合,对侵袭性真菌感染表现出显著的协同作用. 这种组合显示出作为一种新型抗真菌策略的承诺,用于免疫功能低下的患者.

科学领域:

菌类学菌类学是指菌类学.
药理学药理学是指药理学的学科.
传染性疾病传染性疾病

背景情况:

侵袭性真菌感染 (IFI) 构成重大威胁,特别是对免疫功能低下的个体,由于其高患病率和死亡率.
新的治疗策略对于应对国际金融机构日益增长的挑战至关重要.

研究的目的:

为了研究 Baicalein (BE) 与醇抗真菌剂结合的协同抗真菌活性.
为了评估与伊特拉可纳 (ITC),伏利可纳 (VRC),波萨可纳 (POS) 和伊萨武可纳 (ISV) 结合的BE对各种真菌菌株的疗效.

主要方法:

使用标准的M38-A2微乳液稀释方法来确定最小抑制度 (MIC) 和分数抑制度指数 (FICI).
测试了54种Aspergillus菌株和23种除菌菌株,与四种醇抗真菌剂结合对BE进行了测试.

主要成果:

拜卡莱因/波萨科纳 (BE/POS) 组合显示出强大的协同效应,对抗87.04%的阿斯伯吉卢菌和95.65%的细菌菌.
拜卡莱因/伊特拉科纳 (BE/ITC) 的协同作用明显较低 (33.33%的阿斯伯吉勒斯菌,8.70%的细菌菌).
没有观察到与BE / voriconazole (VRC) 或BE / isavuconazole (ISV) 的协同作用.

结论:

BE/POS组合是最有效的抗真菌策略in vitro,在关键的真菌病原体上表现出广泛的协同作用.
BE/POS代表了一种有前途的新型治疗方法,用于管理侵入性真菌感染.

关键词:

亚斯珀吉洛斯 (Aspergillus) 是一种植物.巴伊卡莱因 (Baicalein) 是一种植物.这种类型的海底真菌.这是伊特拉可纳.波萨可纳佐 (Posaconazole) 是一种可以协同效应是一种协同效应.

更多相关视频

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening

Published on: July 18, 2012

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

相关概念视频

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...